Epigenetics alternation in lung fibrosis and lung cancer
Respiratory disease including interstitial lung diseases (ILDs) and lung cancer is a group of devastating diseases that linked with increased morbidity and healthcare burden. However, respiratory diseases cannot be fully explained by the alternation of genetic information. Genetic studies described...
Main Authors: | Xueren Li, Chunjing Feng, Shouchun Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2022.1060201/full |
Similar Items
-
Epigenetic Therapy in Lung Cancer
by: Stephen V Liu, et al.
Published: (2013-05-01) -
Epigenetics as a versatile regulator of fibrosis
by: Yangdan Liu, et al.
Published: (2023-03-01) -
Progress of Epigenetic Methylation in Lung Cancer Research
by: Shaowei ZHANG, et al.
Published: (2017-09-01) -
Epigenetic mechanisms and their effects on cancer incidence and treatment: a review study
by: Reyhane Hoshyar, et al.
Published: (2015-07-01) -
Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead
by: Runping Liu, et al.
Published: (2024-03-01)